< CROM Grand Rounds Announcement – February 8, 2019 – Speaker: Andrew Karasick, MD, MBA, MPH - EOHSI


Provided by Robert Wood Johnson Medical School,

Department of Environmental and Occupational Medicine, and the

 Rutgers School of Public Health, Center for Public Health Workforce Development


Minimally Invasive Cannabinoid Testing

EOHSI Piscataway, NJ Conf. Rooms A&B

Friday, February 8, 2019 (1:00 pm – 2:00 pm)

Andrew Karasick, MD, MBA, MPH


Piscataway, NJ


At the conclusion of this activity, participants should be better able to:

  • Review the changing legislative and judicial climate imposed obligations on employers (including the medical center) and on practitioners.
  • Recognize the causes or influence of environmental/occupational exposures.
  • Identify new hazards and new epidemiologic evidence on casation and prevention accumulating in the field of occupational and environmental health.


In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians:  Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Declarations

Pauline Thomas, MD has the following relevant financial relationships to disclose: employed by Summit Medical Group

Speakers are required to disclose discussion of off-label/investigational uses of commercial products/devices in their presentation.  These disclosures will be made to the audience at the time of the activity.

Planning Committee:

Drs. Michael Gochfeld, Michael Pratt (Content Reviewer) and Mitchel Rosen  have no relevant financial relationships to disclose.